Financhill
Back

Salesforce Vs. Lyra Therapeutics Industry Stock Comparison

Buy
52

CRM
Salesforce

Last Price:
$269.89
Seasonality Move:
10.07%
Sell
15

LYRA
Lyra Therapeutics

Last Price:
$7.99
Seasonality Move:
-2.43%
Buy
52
Salesforce (CRM) is a Buy

Is Salesforce a Buy, Sell or Hold?

  • The current Salesforce [CRM] share price is $267.70. The Score for CRM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics a Buy, Sell or Hold?

  • The current Lyra Therapeutics [LYRA] share price is $8.14. The Score for LYRA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • LYRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CRM Stock Price Chart

What is Salesforce's stock price today?

  • The Salesforce share price today is $267.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight buying pressure.

LYRA Stock Price Chart

What is Lyra Therapeutics's stock price today?

  • The Lyra Therapeutics share price today is $8.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing slight buying pressure.

CRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.9 Sell
Relative Strength Index (14 RSI): 52.92 Buy
Chaikin Money Flow: 738647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (260.5 - 271.28) Buy
Bollinger Bands (100): (257.56 - 282.56) Sell

LYRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Sell
Relative Strength Index (14 RSI): 42.09 Sell
Chaikin Money Flow: 418 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 262.32 Buy
20-day SMA: 266.24 Buy
50-day SMA: 269.97 Sell
200-day SMA: 296.49 Sell
8-day EMA: 264.38 Buy
20-day EMA: 264.98 Buy
50-day EMA: 258.72 Buy
200-day EMA: 155.66 Buy

LYRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0 Buy
20-day SMA: 0 Buy
50-day SMA: 0 Buy
200-day SMA: 0 Buy
8-day EMA: 0 Buy
20-day EMA: 0 Buy
50-day EMA: 0 Buy
200-day EMA: 0 Buy

Salesforce Earnings Growth & CRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.

Lyra Therapeutics Earnings Growth & LYRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

Salesforce Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):